Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. 詳細を表示
CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.3851 | -42.3186813187 | 0.91 | 0.93 | 0.52 | 473391 | 0.72521701 | CS |
| 4 | -0.4651 | -46.9797979798 | 0.99 | 1.25 | 0.52 | 139353 | 0.77600411 | CS |
| 12 | -1.3051 | -71.3169398907 | 1.83 | 1.91 | 0.52 | 75618 | 0.91614566 | CS |
| 26 | -1.5051 | -74.1428571429 | 2.03 | 2.625 | 0.52 | 39025 | 1.01482775 | CS |
| 52 | -0.5751 | -52.2818181818 | 1.1 | 2.625 | 0.52 | 29835 | 1.21375193 | CS |
| 156 | -3.6751 | -87.5023809524 | 4.2 | 7.15 | 0.52 | 37170 | 3.04241645 | CS |
| 260 | -3.6751 | -87.5023809524 | 4.2 | 7.15 | 0.52 | 37170 | 3.04241645 | CS |
tw0122
1週前
Invest-in-America
1週前
tw0122
1週前
Invest-in-America
1週前
glenn1919
2月前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
